- 10x Genomics (NASDAQ:TXG) wait Q4 revenue of ~$165M, representing 9% Q/Q growth and 10% YoY decline; the number remains above the consensus estimates of 153.51 million dollars.
- The highest year-on-year growth is estimated to come from the services segment, while instruments